Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oscar Health ( (OSCR) ) has provided an update.
On September 18, 2025, Oscar Health, Inc. issued $410 million in Convertible Senior Subordinated Notes due 2030, with net proceeds of approximately $395.8 million. The funds will support strategic initiatives, including AI-driven expansion and enhanced consumer healthcare experiences, while also addressing potential growth opportunities like premium tax credits.
The most recent analyst rating on (OSCR) stock is a Sell with a $11.00 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.
Spark’s Take on OSCR Stock
According to Spark, TipRanks’ AI Analyst, OSCR is a Outperform.
Oscar Health’s strong financial performance and positive technical indicators are the primary drivers of its stock score. However, the negative P/E ratio and operational challenges highlighted in the earnings call weigh down the overall score. The company’s strategic initiatives and future profitability goals provide a cautiously optimistic outlook.
To see Spark’s full report on OSCR stock, click here.
More about Oscar Health
Oscar Health, Inc. operates in the health insurance industry, focusing on providing innovative healthcare solutions. The company leverages technology and strategic initiatives to enhance consumer healthcare experiences, lower the cost of care, and support future expansion.
Average Trading Volume: 27,018,122
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.59B
For an in-depth examination of OSCR stock, go to TipRanks’ Overview page.